Cargando…
A Review on MS-Based Blood Biomarkers for Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia and there is no cure to date. Biomarkers in cerebrospinal fluid (CSF) are already included in the diagnostic work-up of symptomatic patients but markers for preclinical diagnosis and disease progression are not available....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908529/ https://www.ncbi.nlm.nih.gov/pubmed/31833028 http://dx.doi.org/10.1007/s40120-019-00165-4 |